Taking into account the opposite effects of adiponectin and resistin, it was suggested that the interplay between these two adipokines may determine the metabolic profile of obese individuals and, possibly, be responsible for the development of obesity-related complications. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.